FindTrial
Sign In

Methylprednisolone acetate versus dexamethasone injection for trigger finger

Methylprednisolone acetate versus dexamethasone injection for trigger finger: A double-blind randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170427001
Enrollment
Unknown
Registered
2017-04-27
Start date
2014-12-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger finger Clinical trial corticosteroid injection triggers finger methylprednisolone acetate dexamethasone

Interventions

Two milliliters of methylprednisolone acetate is mixed with a half milliliter of 1% lidocaine without adrenaline. Additional treatments including a second injection is allowed by the patient at 6 week
up,Two milliliters of dexamethasone is mixed with a half milliliter of 1% lidocaine without adrenaline. Additional treatments including a second injection is allowed by the patient at 6 week follow&#4
Active Comparator Drug,Active Comparator Drug
methylprednisolone acetate,dexamethasone

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18 – 65 years Trigger digit No history of intraarticular steroid injection

Exclusion criteria

Exclusion criteria: Inflammatory or autoimmune arthritis Rheumatoid arthritis Prior tendon injury of the involved digit A current or suspected pregnancy, and breast-feeding Infection site of injection Systematic steroid use Giant cell tumor of tendon sheath Steroid allergy No anticoagulant therapy No bleeding disorder Xylocaine allergy Multiple digits of trigger finger (≥2)

Design outcomes

Primary

MeasureTime frame
Absence of triggering 2-week, 6-week, 12-week, 24-week follow up Quinnell grade,Absence of triggering 2-week, 6-week, 12-week, 24-week follow up Quinnell grade,Absence of triggering 2-week, 6-week, 12-week, 24-week follow up Quinnell grade,Absence of triggering 2-week, 6-week, 12-week, 24-week follow up Quinnell grade,Absence of triggering 2-week, 6-week, 12-week, 24-week follow up Quinnell grade—

Secondary

MeasureTime frame
Recurrence rate of trigger finger 2-week, 6-week, 12-week, 24-week follow up Quinnell grade,Tendon rupture 2-week, 6-week, 12-week, 24-week follow up Clinical by flexion and extension,infection 2-week, 6-week, 12-week, 24-week follow up Sign of infection,DASH score 2-week, 6-week, 12-week, 24-week follow up DASH score,Stiffness 2-week, 6-week, 12-week, 24-week follow up Symptom,Visual analog scale 2-week, 6-week, 12-week, 24-week follow up VAS score—

Countries

Thailand

Contacts

Public ContactChaiwat Chuaychoosakoon

Prince of Songkla University

chaiwatst@hotmail.com+66649696546

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026